Table of Content - Monoclonal Antibodies For Cancer And Non Cancer Diagnostics Market

The global monoclonal antibodies for cancer and non-cancer diagnostics market is estimated to be valued at USD 10,129.3 Mn in 2026 and is expected to reach USD 18,291.2 Mn by 2033, exhibiting a compound annual growth rate (CAGR) of 8.8% from 2026 to 2033. The global monoclonal antibodies for cancer and non-cancer diagnostics market includes a diverse range of diagnostic products that are based on monoclonal antibodies. These antibody-based diagnostics are used to detect, distinguish, and manage a variety of diseases across different clinical indications, including oncology, infectious diseases, autoimmune diseases, and cardiovascular diseases. Due to their high levels of specificity and sensitivity, monoclonal antibodies find widespread use in several high-throughput techniques such as immunohistochemistry (IHC), enzyme-linked immunosorbent assay (ELISA), flow cytometry, and companion diagnostics.

An increasing incidence of cancer, rising requirement for companion diagnostics and advancements in pathology and molecular diagnostic platforms are the key factors pushing the market’s expansion. The expansion of monoclonal antibody applications in infectious disease diagnostics, the management of autoimmune disease and personalized therapy selection will continue to fuel adoption and cement monoclonal antibodies' status as crucial tools in the diagnostic arsenal across hospitals, diagnostic labs, and research organizations.

Market Dynamics

The global monoclonal antibodies for cancer and non-cancer diagnostics market is driven by the increasing number of chronic diseases that need prompt and effective diagnosis, such as cancer, autoimmune disorders, and infectious diseases. Furthermore, the expanding application of precision medicine coupled with a rising demand for companion diagnostics to guide patient treatments for personalized medicines will aid market expansion. Monoclonal antibodies are widely adopted in various diagnostic methods like ELISA, IHC, flow cytometry, and biomarker testing, resulting in augmented use and thus driving the market growth.

However, a number of constraints are present in the market, such as cost-intensive development and validation processes, as well as the need for thorough regulatory approvals. Nevertheless, robust demand for an earlier detection of the disease coupled with increased spending on cancer diagnostics, a growth in the use of multiplex biomarker tests for the precise diagnostics of the disease, and the increased uptake of companion tests are expected to provide lucrative opportunities for the market participants.

Key Features of the Study

This report provides in-depth analysis of the global monoclonal antibodies for cancer and non-cancer diagnostics market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global monoclonal antibodies for cancer and non-cancer diagnostics market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include F. Hoffmann-La Roche Ltd., Agilent Technologies, Inc., Danaher Corporation, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., Abbott Laboratories, QIAGEN N.V., Merck KGaA, Abcam plc, and Sino Biological, Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global monoclonal antibodies for cancer and non-cancer diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global monoclonal antibodies for cancer and non-cancer diagnostics market

Market Segmentation

Antibody Type Insights (Revenue, USD Mn, 2021 - 2033)
- Murine Antibodies
- Rabbit Antibodies
- Chimeric Antibodies
- Humanized Antibodies
- Fully Human Antibodies
- Recombinant Antibodies
- Others
Usage Techniques Insights (Revenue, USD Mn, 2021 - 2033)
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Chemiluminescent Immunoassay (CLIA)
- Western Blot (WB)
- Immunohistochemistry (IHC)
- Immunoprecipitation (IP)
- Immunofluorescence (IF)
- Lateral Flow Assay
- Others
Application Insights (Revenue, USD Mn, 2021 - 2033)
- Cancer
- Obstetrics
- Dengue
- Chikungunya
- Helicobacter pylori
- Syphilis
- HIV (Human immunodeficiency virus)
- Others
End User Insights (Revenue, USD Mn, 2021 - 2033)
- Clinical and Diagnostic Laboratories
- Hospitals
- Biopharmaceutical Companies
- Research Institutions
- Others
Distribution Channel Insights (Revenue, USD Mn, 2021 - 2033)
- Offline
- Online
Regional Insights (Revenue, USD Mn, 2021 - 2033)
- North America
  - U.S.
  - Canada
- Latin America
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
- Europe
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
- Asia Pacific
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
- Middle East
  - GCC Countries
  - Israel
  - Rest of Middle East
- Africa
  - South Africa
  - North Africa
  - Central Africa
Key Players Insights
- F. Hoffmann-La Roche Ltd.
- Agilent Technologies, Inc.
- Danaher Corporation
- Thermo Fisher Scientific Inc.
- Bio-Rad Laboratories, Inc.
- Abbott Laboratories
- QIAGEN N.V.
- Merck KGaA
- Abcam plc
- Sino Biological, Inc.

Table of Contents

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Global Monoclonal Antibodies for Cancer and Non-Cancer Diagnostics Market, By Antibody Type
  - Global Monoclonal Antibodies for Cancer and Non-Cancer Diagnostics Market, By Usage Techniques
  - Global Monoclonal Antibodies for Cancer and Non-Cancer Diagnostics Market, By Application
  - Global Monoclonal Antibodies for Cancer and Non-Cancer Diagnostics Market, By End User
  - Global Monoclonal Antibodies for Cancer and Non-Cancer Diagnostics Market, By Distribution Channel
  - Global Monoclonal Antibodies for Cancer and Non-Cancer Diagnostics Market, By Region
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER’s Analysis
- Market Opportunities
- Regulatory Scenario
- Industry Trends
Global Monoclonal Antibodies for Cancer and Non-Cancer Diagnostics Market, By Antibody Type, 2021-2033, (USD Mn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 - 2033
  - Segment Trends
- Murine Antibodies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Rabbit Antibodies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Chimeric Antibodies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Humanized Antibodies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Fully Human Antibodies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Recombinant Antibodies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Others
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Global Monoclonal Antibodies for Cancer and Non-Cancer Diagnostics Market, By Usage Techniques, 2021-2033, (USD Mn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 - 2033
  - Segment Trends
- Enzyme-Linked Immunosorbent Assay (ELISA)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Chemiluminescent Immunoassay (CLIA)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Western Blot (WB)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Immunohistochemistry (IHC)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Immunoprecipitation (IP)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Immunofluorescence (IF)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Lateral Flow Assay
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Others
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Global Monoclonal Antibodies for Cancer and Non-Cancer Diagnostics Market, By Application, 2021-2033, (USD Mn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 - 2033
  - Segment Trends
- Cancer
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Obstetrics
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Dengue
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Chikungunya
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Helicobacter pylori
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Syphilis
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- HIV (Human immunodeficiency virus)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Others
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Global Monoclonal Antibodies for Cancer and Non-Cancer Diagnostics Market, By End User, 2021-2033, (USD Mn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 - 2033
  - Segment Trends
- Clinical and Diagnostic Laboratories
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Hospitals
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Biopharmaceutical Companies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Research Institutions
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Others
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Global Monoclonal Antibodies for Cancer and Non-Cancer Diagnostics Market, By Distribution Channel, 2021-2033, (USD Mn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 - 2033
  - Segment Trends
- Offline
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Online
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Global Monoclonal Antibodies for Cancer and Non-Cancer Diagnostics Market, By Region, 2021 - 2033, Value (USD Mn)
- Introduction
  - Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)
  - Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
  - Regional Trends
- North America
  - Introduction
  - Market Size and Forecast, By Antibody Type, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Usage Techniques, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
    - U.S.
    - Canada
- Latin America
  - Introduction
  - Market Size and Forecast, By Antibody Type, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Usage Techniques, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
    - Brazil
    - Argentina
    - Mexico
    - Rest of Latin America
- Europe
  - Introduction
  - Market Size and Forecast, By Antibody Type, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Usage Techniques, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
    - Germany
    - U.K.
    - Spain
    - France
    - Italy
    - Russia
    - Rest of Europe
- Asia Pacific
  - Introduction
  - Market Size and Forecast, By Antibody Type, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Usage Techniques, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
    - China
    - India
    - Japan
    - Australia
    - South Korea
    - ASEAN
    - Rest of Asia Pacific
- Middle East
  - Introduction
  - Market Size and Forecast, By Antibody Type, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Usage Techniques, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
    - GCC Countries
    - Israel
    - Rest of Middle East
- Africa
  - Introduction
  - Market Size and Forecast, By Antibody Type, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Usage Techniques, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
    - South Africa
    - North Africa
    - Central Africa
Competitive Landscape
- F. Hoffmann-La Roche Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Agilent Technologies, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Danaher Corporation
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Thermo Fisher Scientific Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Bio-Rad Laboratories, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Abbott Laboratories
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- QIAGEN N.V.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Merck KGaA
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Abcam plc
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Sino Biological, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
References and Research Methodology
- References
- Research Methodology
- About us

*Browse 32 market data tables and 28 figures on ‘Monoclonal Antibodies for Cancer and Non-Cancer Diagnostics Market' - Global forecast to 2033

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now